-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Praxis Precision Medicine, Raises Price Target to $478

Benzinga·11/10/2026 16:17:22
語音播報
RBC Capital analyst Leonid Timashev maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Outperform and raises the price target from $462 to $478.